Alzheimers Dement

1. GILLESPIE NA, Elman JA, McKenzie RE, Tu XM, et al
   The heritability of blood-based biomarkers related to risk of Alzheimer's disease in a population-based sample of early old-age men.
   Alzheimers Dement. 2023 Aug 25. doi: 10.1002/alz.13407.
   

   >> Share

   
   
2. WINCHESTER LM, Harshfield EL, Shi L, Badhwar A, et al
   Artificial intelligence for biomarker discovery in Alzheimer's disease and dementia.
   Alzheimers Dement. 2023 Aug 31. doi: 10.1002/alz.13390.
   

   >> Share

   
   
3. BUSHNELL J, Hammers DB, Aisen P, Dage JL, et al
   Influence of amyloid and diagnostic syndrome on non-traditional memory scores in early-onset Alzheimer's disease.
   Alzheimers Dement. 2023 Aug 31. doi: 10.1002/alz.13434.
   

   >> Share

   
   
4. HARTLEY SL, Handen B, Tudorascu D, Lee L, et al
   AT(N) biomarker profiles and Alzheimer's disease symptomology in Down syndrome.
   Alzheimers Dement. 2023 Aug 28. doi: 10.1002/alz.13446.
   

   >> Share

   
   

   
   Am J Alzheimers Dis Other Demen

5. KUNICKI ZJ, Bayer T, Jiang L, Bozzay ML, et al
   Comparing Lookback Periods to Ascertain Alzheimer's Disease and Related Dementias.
   Am J Alzheimers Dis Other Demen. 2023;38:15333175231199566.
   

   >> Share

   
   

   
   Am J Geriatr Psychiatry

6. KIM JE, Tamres LK, Orbell SL, Cheng RZ, et al
   "And Does That Necessarily Mean Absolutely Alzheimer's?" An Analysis of Questions Raised Following Amyloid PET Results Disclosure.
   Am J Geriatr Psychiatry. 2023 Aug 13:S1064-7481(23)00388.
   

   >> Share

   
   

   
   Brain Res

7. HENRY SM, Kistler SA, Lagani GD, Bartling CRO, et al
   Tight control of the APP-Mint1 interaction in regulating amyloid production.
   Brain Res. 2023;1817:148496.
   

   >> Share

   
   

   
   Curr Alzheimer Res

8. KURHAN F, Akin M
   A New Hope in Alzheimer's Disease Psychosis: Pimavanserin.
   Curr Alzheimer Res. 2023 Aug 25. doi: 10.2174/1567205020666230825124922.
   

   >> Share

   
   
9. SHENG C, Chu X, He Y, Ding Q, et al
   Alterations in Peripheral Metabolites as Key Actors in Alzheimer's Disease.
   Curr Alzheimer Res. 2023 Aug 25. doi: 10.2174/1567205020666230825091147.
   

   >> Share

   
   
10. GU L, Shu H, Wang Y, Wang P, et al
    Blood Neurofilament Light Chain in Different Types of Dementia.
    Curr Alzheimer Res. 2023;20:149-160.
    

    >> Share

    
    

    
    Curr Opin Neurol

11. WANG YT, Rosa-Neto P, Gauthier S
    Advanced brain imaging for the diagnosis of Alzheimer disease.
    Curr Opin Neurol. 2023 Aug 4. doi: 10.1097/WCO.0000000000001198.
    

    >> Share

    
    

    
    J Alzheimers Dis

12. RAMOS C, Madrigal C, Aguirre-Acevedo DC, Giraldo-Chica M, et al
    Psychological Status of the Participants in Alzheimer's Prevention Initiative Autosomal Dominant Alzheimer's Disease Colombia.
    J Alzheimers Dis. 2023 Aug 24. doi: 10.3233/JAD-220941.
    

    >> Share

    
    
13. ABYADEH M, Yadav VK, Kaya A
    Common Molecular Signatures Between Coronavirus Infection and Alzheimer's Disease Reveal Targets for Drug Development.
    J Alzheimers Dis. 2023 Aug 22. doi: 10.3233/JAD-230684.
    

    >> Share

    
    
14. JIANG J, Wang A, Liu Y, Yao Z, et al
    Spatiotemporal Characteristics of Regional Brain Perfusion Associated with Neuropsychiatric Symptoms in Patients with Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 23. doi: 10.3233/JAD-230499.
    

    >> Share

    
    
15. UCHIDA Y, Onda K, Hou Z, Troncoso JC, et al
    Microstructural Neurodegeneration of the Entorhinal-Hippocampus Pathway along the Alzheimer's Disease Continuum.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230452.
    

    >> Share

    
    
16. LI J, Mountz EJ, Mizuno A, Shah AM, et al
    Functional Asymmetry During Working Memory and Its Association with Markers of Alzheimer's Disease in Cognitively Normal Older Adults.
    J Alzheimers Dis. 2023 Aug 24. doi: 10.3233/JAD-230379.
    

    >> Share

    
    
17. KIM DY, Kim JS, Seo YS, Park WY, et al
    Evaluation of Efficacy and Safety Using Low Dose Radiation Therapy with Alzheimer's Disease: A Protocol for Multicenter Phase II Clinical Trial.
    J Alzheimers Dis. 2023 Aug 23. doi: 10.3233/JAD-230241.
    

    >> Share

    
    
18. WU Y, Eisel ULM
    Microglia-Astrocyte Communication in Alzheimer's Disease.
    J Alzheimers Dis. 2023 Aug 25. doi: 10.3233/JAD-230199.
    

    >> Share

    
    

    
    J Biol Chem

19. KURTH V, Ogorek I, Munch C, Lopez-Rios J, et al
    Pathogenic Abeta production by heterozygous PSEN1 mutations is intrinsic to the mutant protein and not mediated by conformational hindrance of wild-type PSEN1.
    J Biol Chem. 2023;299:104997.
    

    >> Share

    
    
20. XIE J, Wu S, Szadowski H, Min S, et al
    Developmental Pb exposure increases AD risk via altered intracellular Ca(2+) homeostasis in hiPSC-derived cortical neurons.
    J Biol Chem. 2023;299:105023.
    

    >> Share

    
    

    
    J Neurosci

21. YAO AY, Halloran PJ, Ge Y, Singh N, et al
    Bace1 deletion in the adult reverses epileptiform activity and sleep-wake disturbances in AD mice.
    J Neurosci. 2023 Aug 3:JN-RM-2124-22. doi: 10.1523/JNEUROSCI.2124-22.2023.
    

    >> Share

    
    

    
    Nat Rev Neurol

22. NAG S, Schneider JA
    Limbic-predominant age-related TDP43 encephalopathy (LATE) neuropathological change in neurodegenerative diseases.
    Nat Rev Neurol. 2023;19:525-541.
    

    >> Share

    
    

    
    Nervenarzt

23. SCHAFFER E, Piel J
    [The exposome in the context of preventive measures for Alzheimer's and Parkinson's diseases].
    Nervenarzt. 2023 Aug 28. doi: 10.1007/s00115-023-01538.
    

    >> Share

    
    

    
    Neurobiol Aging

24. GROECHEL RC, Tripodis Y, Alosco ML, Mez J, et al
    Biomarkers of Alzheimer's disease in Black and/or African American Alzheimer's Disease Neuroimaging Initiative (ADNI) participants.
    Neurobiol Aging. 2023;131:144-152.
    

    >> Share

    
    

    
    Neurobiol Dis

25. GIUFFRE GM, Quaranta D, Costantini EM, Citro S, et al
    Cerebrospinal fluid neurofilament light chain and total-tau as biomarkers of neurodegeneration in Alzheimer's disease and frontotemporal dementia.
    Neurobiol Dis. 2023 Aug 29:106267. doi: 10.1016/j.nbd.2023.106267.
    

    >> Share

    
    

    
    Neurology

26. EDLAND SD, Ucsd, Llibre-Guerra JJ
    Semorinemab in Mild to Moderate Alzheimer Disease: A Glimmer of Hope Though Cautions Remain.
    Neurology. 2023 Aug 29:10.1212/WNL.0000000000207861.
    

    >> Share

    
    
27. MONTEIRO C, Toth B, Brunstein F, Bobbala A, et al
    A Randomized Phase II Study of the Safety and Efficacy of Semorinemab in Participants with Mild-to-Moderate Alzheimer's Disease (Lauriet).
    Neurology. 2023 Aug 29:10.1212/WNL.0000000000207663.
    

    >> Share

    
    

    
    Neuroscience

28. ELDEEN MAKKI B, Rahman S
    Alzheimer's Disease in Diabetic Patients: A Lipidomic Prospect.
    Neuroscience. 2023 Aug 29:S0306-4522(23)00402.
    

    >> Share

    
    

    
    PLoS One

29. ROVANG MS, Selnes P, MacIntosh BJ, Rasmus Groote I, et al
    Segmenting white matter hyperintensities on isotropic three-dimensional Fluid Attenuated Inversion Recovery magnetic resonance images: Assessing deep learning tools on a Norwegian imaging database.
    PLoS One. 2023;18:e0285683.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

30. LE GUEN Y, Luo G, Ambati A, Damotte V, et al
    Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes.
    Proc Natl Acad Sci U S A. 2023;120:e2302720120.
    

    >> Share

    
    
31. CHEN ZL, Singh PK, Calvano M, Norris EH, et al
    A possible mechanism for the enhanced toxicity of beta-amyloid protofibrils in Alzheimer's disease.
    Proc Natl Acad Sci U S A. 2023;120:e2309389120.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share